Skip to content

R&D at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$345M+0.3%
ITG
Integer HoldingsITGR
$16.24M+14.4%
Medtronic logo
MedtronicMDT
$671M-1.9%
Edwards Lifesciences logo
Edwards LifesciencesEW
$263.3M+3.4%

Other financials

Income statement

See full
Revenue$52.6M+41.3%
Gross profit$42.2M+50.9%
Operating income-$29.5M-68.6%
Net income-$27.4M+15.4%
EPS (diluted)-$0.32+93.9%

Balance sheet

See full
Cash & equivalents$24.4M-78.7%
Total debt$26.3M
Total equity$285.7M+132%
Total assets$344.0M

Cash flow

See full
Operating cash flow-$30.1M-129%
CapEx$1.9M+71.6%
Free cash flow-$32.0M-124%

Valuation

See full
Market cap$2.97B
Enterprise value$2.98B
P/S15.5×

Profitability

See full
Gross margin78.1%+2.4pp
Operating margin-39.7%-4.8pp
Net margin-58.4%-12.1pp
FCF margin-40.1%-2.4pp

Returns & leverage

See full
Return on equity37.1%
Debt / equity0.1×
Current ratio5.6×

Where this comes from

Reported directly by HTFL in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: HTFL’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about HTFL's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HTFL's R&D?
HTFL (HTFL) reported R&D of $21.62M in Q1 2026.
How has HTFL's R&D changed year-over-year?
HTFL's R&D increased by 55.3% year-over-year, from $13.92M to $21.62M.
What is the long-term trend for HTFL's R&D?
Over 2 years (2023 to 2025), HTFL's R&D has grown at a 34.6% compound annual growth rate (CAGR), from $35.85M to $64.92M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.